GERICARE SORBITOL SOLUTION- sorbitol liquid 
GERI-CARE PHARMACEUTICALS, CORP

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredient

Sorbitol 70% USP

Purpose

Laxative

Uses

Warnings

For rectal use only

Do not use

Ask a doctor before use if

Stop use and aska doctor if you have a rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition.

If pregnant or breast feeding ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions Do not exceed recommended dose

 AGE DOSE
 Adults and children 12 years and over For rectal use only. Enema dosage is 120 mL of a 25 to 30% w/v solution (1 part of this product with 2.3 parts water) in a single daily dose as needed, or as directed by your doctor.
 Children under 12 years of age Ask a doctor

Inactive ingredients water

Questions or comments? 1-800-540-3765

image descriptionimage description

GERICARE SORBITOL SOLUTION 
sorbitol liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-758
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SORBITOL (UNII: 506T60A25R) (SORBITOL - UNII:506T60A25R) SORBITOL70 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-758-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product01/01/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33401/01/2020
Labeler - GERI-CARE PHARMACEUTICALS, CORP (611196254)

Revised: 12/2020
Document Id: 413c3c8f-57c6-4c2a-8589-87340ebb96d3
Set id: b4dd7a41-380e-d94b-e053-2a95a90ac34a
Version: 3
Effective Time: 20201229
 
GERI-CARE PHARMACEUTICALS, CORP